+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Research-grade Proteins Market Size, Share & Trends Analysis Report By Product (Cytokines & Growth Factors, Antibodies), By Host Cell (Mammalian Cells, Bacterial Cells), By End-use, By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 160 Pages
  • September 2023
  • Region: Global
  • Grand View Research
  • ID: 5893149
Description Jump to:
The global research-grade proteins market size is estimated to reach USD 2.69 billion by 2030, growing at a CAGR of 15.53% from 2023 to 2030. The growing investments in research and development within the fields of cancer research and rising demand for personalized medicines are anticipated to contribute to the growth of the market. In addition, the rising government investments in numerous countries for various clinical studies are expected to drive the growth of the market. Moreover, the growing advancements in the biotechnology industry in developing countries are further driving the growth of the market over the forecast period.

The COVID-19 pandemic positively impacted the market due to the surge in research activities for developing vaccines, diagnostics, and therapeutics. As regulatory authorities focused on expediting the approval processes for vaccine candidates, the demand for contract manufacturing increased. Although novel vaccine platforms, such as mRNA vaccines, received significant attention, several recombinant protein vaccine alternatives were also being evaluated. For instance, in July 2022, Novavax, Inc.’s Nuvaxovid (NVX-CoV2373) recombinant protein-based COVID-19 vaccine received an expanded conditional marketing authorization for use in the EU. Furthermore, the pandemic highlighted the need for agile and flexible manufacturing abilities in biologics. This factor is expected to boost the competitive landscape and fuel market growth in the near future.

As per Global Genes, in October 2019, more than 400 million people globally are living with rare and genetic diseases. This figure indicates the dire need for treatments and the betterment of clinical settings as well as health awareness. The need for advanced research and drug targeting mechanisms knowledge is crucial for medicine development. Many regions have developed biobanks from cohort programs to provide researchers with high-quality samples for revolutionizing treatment efforts. This is expected to result in an increased focus on biomarkers discovery for various conditions. Thus, initiatives and government interest in research activities for building a better healthcare infrastructure are expected to enhance the applications of research-grade proteins, consequently driving market growth.

However, protein production is a time-consuming activity, which often requires high maintenance of the operating conditions during the procedure. Even with the high and ever-increasing demand for these recombinant products, support from regulatory bodies is still evolving at a slower pace. Research-grade proteins are usually manufactured via a host or an expression system, where the gene specific to the desired product is expressed through stages of transfection and bacterial transformation or viral transduction. This complex process often has the disadvantage of over-expression of untargeted regions and even utilizes more time. Thus, the absence of specific guidelines and regulations for recombinant technology is a major factor hindering the booming market of research-grade proteins.

Research-grade Proteins Market Report Highlights

  • Based on product, the cytokines & growth factors segment dominated the market with the largest revenue share of 23.36% in 2022 and the segment is anticipated to grow with the fastest CAGR of 17.62% over the forecast period. This can be attributed to its role in various clinical studies for drug discovery and development
  • Based on host cell, the mammalian cells segment dominated the market with the largest revenue share of 55.73% in 2022. The large share is primarily due to its similar biological makeup to human cells, which helps in the production of biopharmaceuticals, including monoclonal antibodies, vaccines, and many more
  • Based on end-use, the pharmaceutical & biotechnology companies segment held the largest market share of 61.35% in 2022. Due to the increasing number of research activities for drug discoveries & development and the growing demand for personalized medicines, the demand for research-grade proteins is projected to boost over the forecast period
  • Based on region, North America dominated the market with a revenue share of 44.86% in 2022. This large share is attributed to the presence of major market players and robust healthcare infrastructure. These factors are anticipated to boost the market for research-grade proteins in the region over the forecast period

Table of Contents

Chapter 1. Research-grade Proteins Market: Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Product Segment
1.2.2. Host Cell Segment
1.2.3. End-use Segment
1.3. Research Assumptions
1.4. Information Procurement
1.4.1. Primary Research
1.5. Information or Data Analysis
1.6. Market Formulation & Validation
1.7. Market Model
1.8. Global Market: CAGR Calculation
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Research-grade Proteins Market: Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Research-grade Proteins Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Increasing use of recombinant proteins in research activities
3.3.2. Growing research activities for drug discovery and precision medicine
3.3.3. Rising adoption of biologics & biosimilars
3.4. Market Restraint Analysis
3.4.1. Regulatory and safety concerns regarding protein production
3.4.2. Dearth of skilled personnel and expertise
3.5. Business Environment Analysis
3.5.1. PESTEL Analysis
3.5.2. Porter’s Five Forces Analysis
3.5.3. COVID-19 Impact Analysis
Chapter 4. Product Business Analysis
4.1. Research-grade Proteins Market: Product Movement Analysis
4.2. Cytokines & Growth Factors
4.2.1. Cytokines & Growth Factors Market, 2018 - 2030 (USD Million)
4.2.2. Interferons (IFNs)
4.2.2.1. Interferons (IFNs) Market, 2018 - 2030 (USD Million)
4.2.3. Interleukins (ILs)
4.2.3.1. Interleukins (ILs) Market, 2018 - 2030 (USD Million)
4.2.4. Others
4.2.4.1. Others Market, 2018 - 2030 (USD Million)
4.3. Antibodies
4.3.1. Antibodies, 2018 - 2030 (USD Million)
4.4. Immune Checkpoint Proteins
4.4.1. Immune Checkpoint Proteins Market, 2018 - 2030 (USD Million)
4.5. Virus Antigens
4.5.1. Virus Antigens Market, 2018 - 2030 (USD Million)
4.6. Enzymes
4.6.1. Enzymes Market, 2018 - 2030 (USD Million)
4.6.2. Kinases
4.6.2.1. Kinases Market, 2018 - 2030 (USD Million)
4.6.3. Metabolic Enzymes
4.6.3.1. Metabolic Enzymes Market, 2018 - 2030 (USD Million)
4.6.4. Others
4.6.4.1. Others Market, 2018 - 2030 (USD Million)
4.7. Recombinant Regulatory Proteins
4.7.1. Recombinant Regulatory Proteins Market, 2018 - 2030 (USD Million)
4.8. Hormones
4.8.1. Hormones Market, 2018 - 2030 (USD Million)
4.9. Others
4.9.1. Others Market, 2018 - 2030 (USD Million)
Chapter 5. Host Cell Business Analysis
5.1. Research-grade Proteins Market: Host Cell Movement Analysis
5.2. Mammalian Cells
5.2.1. Mammalian Cells Market, 2018 - 2030 (USD Million)
5.3. Bacterial Cells
5.3.1. Bacterial Cells Market, 2018 - 2030 (USD Million)
5.4. Yeast & Fungi
5.4.1. Yeast & Fungi Market, 2018 - 2030 (USD Million)
5.5. Insect Cells
5.5.1. Insect Cells Market, 2018 - 2030 (USD Million)
5.6. Others
5.6.1. Others Market, 2018 - 2030 (USD Million)
Chapter 6. End-use Business Analysis
6.1. Research-grade Proteins Market: End-use Movement Analysis
6.2. Pharmaceutical & Biotechnology Companies
6.2.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
6.3. Academic & Research Institutes
6.3.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)
6.4. Others
6.4.1. Others Market, 2018 - 2030 (USD Million)
Chapter 7. Regional Business Analysis
7.1. Regional Market Snapshot
7.2. North America
7.2.1. North America Research-grade Proteins Market, 2018 - 2030 (USD Million)
7.2.2. U.S.
7.2.2.1. Key Country Dynamics
7.2.2.2. Competitive Scenario
7.2.2.3. Regulatory Scenario
7.2.2.4. U.S. Research-grade Proteins Market, 2018 - 2030 (USD Million)
7.2.3. Canada
7.2.3.1. Key Country Dynamics
7.2.3.2. Competitive Scenario
7.2.3.3. Regulatory Scenario
7.2.3.4. Canada Research-grade Proteins Market, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. Europe Research-grade Proteins Market, 2018 - 2030 (USD Million)
7.3.2. UK
7.3.2.1. Key Country Dynamics
7.3.2.2. Competitive Scenario
7.3.2.3. Regulatory Scenario
7.3.2.4. UK Research-grade Proteins Market, 2018 - 2030 (USD Million)
7.3.3. Germany
7.3.3.1. Key Country Dynamics
7.3.3.2. Competitive Scenario
7.3.3.3. Regulatory Scenario
7.3.3.4. Germany Research-grade Proteins Market, 2018 - 2030 (USD Million)
7.3.4. Spain
7.3.4.1. Key Country Dynamics
7.3.4.2. Competitive Scenario
7.3.4.3. Regulatory Scenario
7.3.4.4. Spain Research-grade Proteins Market, 2018 - 2030 (USD Million)
7.3.5. France
7.3.5.1. Key Country Dynamics
7.3.5.2. Competitive Scenario
7.3.5.3. Regulatory Scenario
7.3.5.4. France Research-grade Proteins Market, 2018 - 2030 (USD Million)
7.3.6. Italy
7.3.6.1. Key Country Dynamics
7.3.6.2. Competitive Scenario
7.3.6.3. Regulatory Scenario
7.3.6.4. Italy Research-grade Proteins Market, 2018 - 2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Key Country Dynamics
7.3.7.2. Competitive Scenario
7.3.7.3. Regulatory Scenario
7.3.7.4. Denmark Research-grade Proteins Market, 2018 - 2030 (USD Million)
7.3.8. Sweden
7.3.8.1. Key Country Dynamics
7.3.8.2. Competitive Scenario
7.3.8.3. Regulatory Scenario
7.3.8.4. Sweden Research-grade Proteins Market, 2018 - 2030 (USD Million)
7.3.9. Norway
7.3.9.1. Key Country Dynamics
7.3.9.2. Competitive Scenario
7.3.9.3. Regulatory Scenario
7.3.9.4. Norway Research-grade Proteins Market, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia-Pacific Research-grade Proteins Market, 2018 - 2030 (USD Million)
7.4.2. Japan
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. Regulatory Scenario
7.4.2.4. Japan Research-grade Proteins Market, 2018 - 2030 (USD Million)
7.4.3. China
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Regulatory Scenario
7.4.3.4. China Research-grade Proteins Market, 2018 - 2030 (USD Million)
7.4.4. India
7.4.4.1. Key Country Dynamics
7.4.4.2. Competitive Scenario
7.4.4.3. Regulatory Scenario
7.4.4.4. India Research-grade Proteins Market, 2018 - 2030 (USD Million)
7.4.5. South Korea
7.4.5.1. Key Country Dynamics
7.4.5.2. Competitive Scenario
7.4.5.3. Regulatory Scenario
7.4.5.4. South Korea Research-grade Proteins Market, 2018 - 2030 (USD Million)
7.4.6. Thailand
7.4.6.1. Key Country Dynamics
7.4.6.2. Competitive Scenario
7.4.6.3. Regulatory Scenario
7.4.6.4. Thailand Research-grade Proteins Market, 2018 - 2030 (USD Million)
7.4.7. Australia
7.4.7.1. Key Country Dynamics
7.4.7.2. Competitive Scenario
7.4.7.3. Regulatory Scenario
7.4.7.4. Australia Research-grade Proteins Market, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Research-grade Proteins Market, 2018 - 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Regulatory Scenario
7.5.2.4. Brazil Research-grade Proteins Market, 2018 - 2030 (USD Million)
7.5.3. Mexico
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Scenario
7.5.3.4. Mexico Research-grade Proteins Market, 2018 - 2030 (USD Million)
7.5.4. Argentina
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Regulatory Scenario
7.5.4.4. Argentina Research-grade Proteins Market, 2018 - 2030 (USD Million)
7.6. MEA
7.6.1. MEA Research-grade Proteins Market, 2018 - 2030 (USD Million)
7.6.2. South Africa
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Scenario
7.6.2.4. South Africa Research-grade Proteins Market, 2018 - 2030 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Scenario
7.6.3.4. Saudi Arabia Research-grade Proteins Market, 2018 - 2030 (USD Million)
7.6.4. UAE
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Regulatory Scenario
7.6.4.4. UAE Research-grade Proteins Market, 2018 - 2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Regulatory Scenario
7.6.5.4. Kuwait Research-grade Proteins Market, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Market Share/Position Analysis, 2022
8.4. Company Profiles/Listing
8.4.1. Thermo Fisher Scientific, Inc.
8.4.1.1. Company Overview
8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. Abcam Plc
8.4.2.1. Company Overview
8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. Miltenyi Biotec
8.4.3.1. Company Overview
8.4.3.2. Product Benchmarking
8.4.3.3. Strategic Initiatives
8.4.4. GenScript
8.4.4.1. Company Overview
8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. Bio-Techne
8.4.5.1. Company Overview
8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. Proteintech Group, Inc.
8.4.6.1. Company Overview
8.4.6.2. Product Benchmarking
8.4.6.3. Strategic Initiatives
8.4.7. ACROBiosystems
8.4.7.1. Company Overview
8.4.7.2. Product Benchmarking
8.4.7.3. Strategic Initiatives
8.4.8. Sino Biological, Inc.
8.4.8.1. Company Overview
8.4.8.2. Product Benchmarking
8.4.8.3. Strategic Initiatives
8.4.9. Prospec-Tany Technogene Ltd.
8.4.9.1. Company Overview
8.4.9.2. Product Benchmarking
8.4.9.3. Strategic Initiatives
8.4.10. New England Biolabs
8.4.10.1. Company Overview
8.4.10.2. Product Benchmarking
8.4.10.3. Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 North America research-grade proteins market, by country, 2018 - 2030 (USD Million)
Table 4 North America research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 5 North America research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 6 North America research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
Table 7 U.S. research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 8 U.S research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 9 U.S research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
Table 10 Canada research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 11 Canada research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 12 Canada research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
Table 13 Europe research-grade proteins market, by country, 2018 - 2030 (USD Million)
Table 14 Europe research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 15 Europe research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 16 Europe research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
Table 17 UK research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 18 UK research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 19 UK research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
Table 20 Germany research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 21 Germany research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 22 Germany research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
Table 23 France research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 24 France research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 25 France research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
Table 26 Italy research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 27 Italy research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 28 Italy research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
Table 29 Spain research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 30 Spain research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 31 Spain research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
Table 32 Denmark research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 33 Denmark research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 34 Denmark research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
Table 35 Sweden research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 36 Sweden research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 37 Sweden research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
Table 38 Norway research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 39 Norway research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 40 Norway research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
Table 41 Asia Pacific research-grade proteins market, by country, 2018 - 2030 (USD Million)
Table 42 Asia Pacific research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 43 Asia Pacific research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 44 Asia Pacific research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
Table 45 China research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 46 China research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 47 China research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
Table 48 Japan research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 49 Japan research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 50 Japan research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
Table 51 India research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 52 India research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 53 India research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
Table 54 South Korea research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 55 South Korea research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 56 South Korea research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
Table 57 Australia research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 58 Australia research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 59 Australia research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
Table 60 Thailand research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 61 Thailand research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 62 Thailand research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
Table 63 Latin America research-grade proteins market, by country, 2018 - 2030 (USD Million)
Table 64 Latin America research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 65 Latin America research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 66 Latin America research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
Table 67 Brazil research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 68 Brazil research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 69 Brazil research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
Table 70 Mexico research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 71 Mexico research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 72 Mexico research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
Table 73 Argentina research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 74 Argentina research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 75 Argentina research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
Table 76 Middle East & Africa research-grade proteins market, by country, 2018 - 2030 (USD Million)
Table 77 Middle East & Africa research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 78 Middle East & Africa research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 79 Middle East & Africa research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
Table 80 South Africa research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 81 South Africa research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 82 South Africa research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 84 Saudi Arabia research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 85 Saudi Arabia research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
Table 86 UAE research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 87 UAE research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 88 UAE research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
Table 89 Kuwait research-grade proteins market, by product, 2018 - 2030 (USD Million)
Table 90 Kuwait research-grade proteins market, by host cell, 2018 - 2030 (USD Million)
Table 91 Kuwait research-grade proteins market, by end-use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Market summary
Fig. 4 Market segmentation & scope
Fig. 5 Market size and growth prospects
Fig. 6 Global research-grade proteins market- Key market driver analysis
Fig. 7 Global research-grade proteins market - Key market restraint analysis
Fig. 8 Global research-grade proteins market - Porter’s analysis
Fig. 9 Global research-grade proteins market - PESTEL analysis
Fig. 10 Global research-grade proteins market: Product outlook key takeaways
Fig. 11 Global research-grade proteins market: Product movement analysis
Fig. 12 Cytokines & growth factors market estimates, 2018 - 2030 (USD Million)
Fig. 13 Interferons (IFNs) market estimates, 2018 - 2030 (USD Million)
Fig. 14 Interleukins (ILs) market estimates, 2018 - 2030 (USD Million)
Fig. 15 Others market estimates, 2018 - 2030 (USD Million)
Fig. 16 Antibodies market estimates, 2018 - 2030 (USD Million)
Fig. 17 Immune checkpoint proteins market estimates, 2018 - 2030 (USD Million)
Fig. 18 Virus antigens market estimates, 2018 - 2030 (USD Million)
Fig. 19 Enzymes market estimates, 2018 - 2030 (USD Million)
Fig. 20 Kinases market estimates, 2018 - 2030 (USD Million)
Fig. 21 Metabolic enzymes market estimates, 2018 - 2030 (USD Million)
Fig. 22 Others market estimates, 2018 - 2030 (USD Million)
Fig. 23 Recombinant regulatory proteins market estimates, 2018 - 2030 (USD Million)
Fig. 24 Hormones market estimates, 2018 - 2030 (USD Million)
Fig. 25 Others market estimates, 2018 - 2030 (USD Million)
Fig. 26 Global research-grade proteins market: Host cells outlook key takeaways
Fig. 27 Global research-grade proteins market: Host cells movement analysis
Fig. 28 Mammalian cells market estimates, 2018 - 2030 (USD Million)
Fig. 29 Bacterial cells market estimates, 2018 - 2030 (USD Million)
Fig. 30 Yeast & fungi market estimates, 2018 - 2030 (USD Million)
Fig. 31 Insect cells market estimates, 2018 - 2030 (USD Million)
Fig. 32 Others market estimates, 2018 - 2030 (USD Million)
Fig. 33 Global research-grade proteins market: End-use outlook key takeaways
Fig. 34 Global research-grade proteins market: End-use movement analysis
Fig. 35 Pharmaceutical & biotechnology companies market estimates, 2018 - 2030 (USD Million)
Fig. 36 Academic & research institutes market estimates, 2018 - 2030 (USD Million)
Fig. 37 Others market estimates, 2018 - 2030 (USD Million)
Fig. 38 Regional marketplace: Key takeaways
Fig. 39 Global research-grade proteins market: Regional movement analysis
Fig. 40 North America research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 41 U.S. research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 42 Canada research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 43 Europe research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 44 UK research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 45 Germany research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 46 France research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 47 Spain research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 48 Italy research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 49 Denmark research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 50 Sweden research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 51 Norway research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 52 Asia Pacific research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 53 Japan research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 54 China research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 55 India research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 56 South Korea research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 57 Australia research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 58 Thailand research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 59 Latin America research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 60 Brazil research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 61 Mexico research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 62 Argentina research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 63 MEA research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 64 South Africa research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 65 Saudi Arabia research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 66 UAE research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 67 Kuwait research-grade proteins market, 2018 - 2030 (USD Million)
Fig. 68 Strategy framework

Companies Mentioned

  • Thermo Fisher Scientific, Inc.
  • Abcam Plc
  • Miltenyi Biotec
  • GenScript
  • Bio-Techne
  • Proteintech Group, Inc.
  • ACROBiosystems
  • Sino Biological, Inc.
  • Prospec-Tany Technogene Ltd.
  • New England Biolabs

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages160
PublishedSeptember 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 845.1 Million
Forecasted Market Value ( USD ) by 2030 $ 2690 Million
Compound Annual Growth Rate15.5%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Global Research-grade Proteins Market Size, Share & Industry Trends Analysis Report By Host Cell (Mammalian Cells, Bacterial Cells, Yeast & Fungi, Insect Cells, and Others), By Product, By End-Use, By Regional Outlook and Forecast, 2023 - 2030 - Product Image

Global Research-grade Proteins Market Size, Share & Industry Trends Analysis Report By Host Cell (Mammalian Cells, Bacterial Cells, Yeast & Fungi, Insect Cells, and Others), By Product, By End-Use, By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • Global
From
Global Cytokine Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 - Product Image

Global Cytokine Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

  • Report
  • 183 Pages
  • Global
From
Cytokine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 - Product Image

Cytokine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

  • Report
  • 145 Pages
  • Global
From
Cytokine Release Syndrome - Pipeline Insight, 2024 - Product Image

Cytokine Release Syndrome - Pipeline Insight, 2024

  • Clinical Trials
  • 40 Pages
  • Global
From
Cytokine Testing Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Cytokine Testing Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 94 Pages
  • Global
From

About the Research Grade Proteins Market

The Research Grade Proteins market is a key component of the drug discovery process. Proteins are essential for understanding the structure and function of biological systems, and are used to develop new drugs and therapies. Research grade proteins are produced in a highly controlled environment, ensuring that they are of the highest quality and purity. They are used in a variety of applications, including drug screening, target identification, and biomarker discovery. Research grade proteins are used in a variety of drug discovery processes, including high-throughput screening, structure-based drug design, and protein-protein interaction studies. They are also used in the development of novel therapeutic agents, such as monoclonal antibodies and small molecule drugs. Companies in the Research Grade Proteins market include Abcam, Bio-Techne, Merck KGaA, Thermo Fisher Scientific, and GenScript. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.